AUGUSTINE THERAPEUTICS
Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors for the treatment of axonopathies such as Charcot Marie Tooth disease. These new compounds have the potential to protect from nerve degeneration and promote peripheral myelin and axon repair.
AUGUSTINE THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-03-01
Address:
Leuven, Vlaams-Brabant, Belgium
Country:
Belgium
Website Url:
http://www.augustinetx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
21.2 M EUR
Technology used in webpage:
Google Maps Google Maps API Google Maps For Work Belgian Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Investors List
PMV
PMV investment in Series A - Augustine Therapeutics
V-Bio Ventures
V-Bio Ventures investment in Series A - Augustine Therapeutics
AdBio partners
AdBio partners investment in Series A - Augustine Therapeutics
Eli Lilly
Eli Lilly investment in Series A - Augustine Therapeutics
CMT Research Foundation
CMT Research Foundation investment in Series A - Augustine Therapeutics
Gemma Frisius Fund
Gemma Frisius Fund investment in Series A - Augustine Therapeutics
VIB
VIB investment in Series A - Augustine Therapeutics
Asabys Partners
Asabys Partners investment in Series A - Augustine Therapeutics
AdBio partners
AdBio partners investment in Seed Round - Augustine Therapeutics
PMV
PMV investment in Seed Round - Augustine Therapeutics
Official Site Inspections
http://www.augustinetx.com Semrush global rank: 8.27 M Semrush visits lastest month: 588
- Host name: linweb591.webhosting.be
- IP address: 185.86.18.16
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
More informations about "Augustine Therapeutics"
About Us - Augustine
Augustine Therapeutics was founded in 2019 as a spin-off of VIB and KU Leuven. Based on the groundbreaking neurological research of Prof. Ludo Van Den Bosch, this early drug discovery company is building a portfolio of first-in-class …See details»
Augustine Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors for the …See details»
Augustine Therapeutics awarded with a US ALS Association grant …
Feb 27, 2024 The ALS Association is the largest ALS organization in the world. The Association funds global research collaborations, assists people with ALS and their families through its …See details»
Augustine Therapeutics - LinkedIn
Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies and ...See details»
Augustine Therapeutics strengthens Board of Directors and sets …
Since 1993, Tambuyzer has worked with rare disease patients’ organizations. From 2014 until 2020, he co-founded and chaired an international non-profit organization working on therapies …See details»
Augustine Therapeutics - VentureRadar
"Augustine Therapeutics is a biotech company focused on the development of novel treatments for neurodegenerative and cardiometabolic diseases.See details»
A story of continued growth: the Augustine Tx journey - LinkedIn
Dec 20, 2021 Augustine Therapeutics was created in 2019, thanks to the pioneering research of scientists at the VIB-KU Leuven Center for Brain & Disease Research. The startup’s aim is to …See details»
Augustine Therapeutics: Contact Details and Business Profile
Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies …See details»
Augustine - CMT Research Foundation collaborates with …
Feb 3, 2023 Founded by two patients who are driven to expedite drug delivery to people who live with CMT, the 501(c)(3) federal tax-exempt organization is supported by personal and …See details»
Augustine Therapeutics awarded EUR 1.2 million VLAIO research
Mar 23, 2021 More information at www.augustinetx.com. About VLAIO. The Agency for Innovation and Entrepreneurship (VLAIO) is an organization of the Flemish government for all …See details»
Augustine Therapeutics, a VIB spin-off company, raises EUR 17 …
Ghent, 26 June 2024 – VIB, Flanders’ leading life sciences research institute announces today that one of its spin-off companies, Augustine Therapeutics, has raised EUR 17 million (USD …See details»
Augustine - Augustine Therapeutics announces €17 million Series …
Leuven, Belgium, June 26, 2024 - Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, today …See details»
Augustine Therapeutics Raises EUR 17 Million in a Series A First ...
Jun 26, 2024 For more information visit www.augustinetx.com. About Asabys Partners Asabys Partners (www.asabys.com) is a venture capital firm specialized in the healthcare sector, …See details»
Augustine Therapeutics awarded VLAIO grant - flanders.bio
Mar 23, 2021 www.augustinetx.com. About VLAIO. ... (VLAIO) is an organization of the Flemish government for all entrepreneurs in Flanders. The mission of VLAIO is to stimulate and …See details»
Augustine Therapeutics appoints Gerhard Koenig as Chairman and …
Oct 5, 2022 He has also chaired the elderly task force cancer of the European Organization of Research and Treatment of Cancer (EORTC). ... Email: [email protected]; Share: …See details»
CMT Research Foundation (USA) collaborates with Augustine
Mar 2, 2023 It’s their mission to raise funds to invest in promising science with high potential of leading to treatments and cures. Founded by two patients who are driven to expedite drug …See details»
Augustine Therapeutics strengthens Board of Directors and sets …
Leuven, Belgium, 19 March 2021 - Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare peripheral neuropathies and neurodegenerative …See details»
Augustine Therapeutics Raises EUR 17 Million in a Series A First ...
Jun 26, 2024 Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6 inhibitor, into a first-in-human clinical Phase 1/2 study Gerhard Koenig …See details»